ask="10.85"
ask_size="400"
average_daily_volume="164623"
bid="10.00"
bid_size="900"
book_value="0.00"
change="+0.13"
change_from_200_day_moving_average="6.87"
change_from_50_day_moving_average="1.29"
change_from_52_week_high="-0.12"
change_From_52_week_low="4.30"
change_in_percent="+1.27%"
close="10.40"
dividend_pay_date="6/27/2013"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.47"
ebitda="0.00"
eps_estimate_current_year="-3.65"
eps_estimate_next_quarter="-0.50"
eps_estimate_next_year="-1.78"
ex_dividend_date="6/28/2013"
float_shares="N/A"
high="10.52"
high_52_weeks="10.52"
last_trade_date="2/8/2017"
last_trade_price="10.40"
last_trade_size="1082"
last_trade_time="4:00pm"
low="10.20"
low_52_weeks="6.10"
market_capitalization="N/A"
moving_average_200_day="3.53"
moving_average_50_day="9.11"
name="Novelion Therapeutics Inc. "
notes="N/A"
one_year_target_price="11.87"
open="10.34"
pe_ratio="N/A"
peg_ratio="0.15"
percent_change_from_200_day_moving_average="+194.77%"
percent_change_from_50_day_moving_average="+14.22%"
percent_change_from_52_week_high="-1.14%"
percent_change_from_52_week_low="+70.49%"
previous_close="10.27"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NMS"
symbol="NVLN"
volume="112574"
weeks_range_52="6.10 - 10.52"
